Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10982565 | Thrombosis Research | 2018 | 30 Pages |
Abstract
Increased heparanase levels may be one of the esoteric causes for PVT. UFH treatment may trigger an increase in heparanase levels which may affect the treatment success. Increased heparanase levels may be associated with high risk of thromboembolism and increased thrombus burden in PVT patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Emrah Bayam, Macit Kalçık, Ahmet Seyfeddin Gürbüz, Mahmut Yesin, Ahmet Güner, Sabahattin Gündüz, Mustafa Ozan Gürsoy, Süleyman Karakoyun, Sinan CerÅit, Alev Kılıçgedik, Ãzkan Candan, Ali Yaman, Mehmet Ãzkan,